Sort
15,273 grants matching “antimicrobial resistance”
Development of a cell-based HTS for compounds with activity against tuberculosis
$266,495David G Russell · Cornell University · R01 · FY2011 · AI
Periplasmic Zinc Management and Homeostasis in Paracoccus denitrificans
$266,400Erik T Yukl · New Mexico State University Las Cruces · R01 · FY2022 · GM
Periplasmic Zinc Management and Homeostasis in Paracoccus denitrificans
$266,400Erik T Yukl · New Mexico State University Las Cruces · R01 · FY2020 · GM
Periplasmic Zinc Management and Homeostasis in Paracoccus denitrificans
$266,400Erik T Yukl · New Mexico State University Las Cruces · R01 · FY2021 · GM
Vibrio fischeri as a model of bacterial colonization
$266,340Margaret J Mc Fall-Ngai · University Of Wisconsin-Madison · R01 · FY2006 · AI
ASSESSING IN VITRO/VIVO EFFICACY OF ANTIMALARIAL ENR INHIBITORS
$266,333Texas Agrilife Research · P01 · FY2004 · AI
Apramycin scaffold exploration using novel glycochemistry and SAR studies to enhance activity against Acinetobacter baumannii and other multidrug-resistant Gram-negative pathogens
$266,324James E Kirby · Beth Israel Deaconess Medical Center · R21 · FY2019 · AI
Mechanisms of Burkholderia Drug Tolerance and Pathogenesis
$266,236Martin Inua Voskuil · Colorado State University · U54 · FY2008 · AI
Training in Population Biology of Infectious Diseases
$266,202Leslie A. Real · Emory University · T32 · FY2011 · AI
Fusidic acid derivatization to enhance entry into Gram-negative pathogens
$266,130James E Kirby · Beth Israel Deaconess Medical Center · R21 · FY2019 · AI
THE T-CELL RESPONSE TO ANTIGEN
$266,118Dana-Farber Cancer Institute · R01 · FY2000 · AI
Volatile Metabolite-Based Detection of Clostridium difficile Infection
$266,063Sophia Koo · Brigham And Women'S Hospital · R21 · FY2015 · AI
Systems Biology for Molecular Analysis of Tuberculosis in Ethiopia
$266,053Gobena Ameni · Addis Ababa University · U01 · FY2014 · HG
Molecular mechanisms of microbial complex carbohydrate secretion
$266,020Jochen Zimmer · University Of Virginia · R01 · FY2018 · GM
NMR Fragment-based Design of New b-lactamase Inhibitors
$265,808Mandar T Naik · Brown University · R21 · FY2025 · AI
Structural studies of target recognition by large natural product antibiotics
$265,741Patrick J Loll · Drexel University · R01 · FY2010 · GM
Development of nanobody immunotherapeutics that prevent and treat gonorrhea
$265,676Sanjay Ram · Univ Of Massachusetts Med Sch Worcester · R21 · FY2023 · AI
Using Collaborative Cross mice to develop a novel model of Mycobacterium abscesses lung infection
$265,650Martin Alfons Gengenbacher · Hackensack University Medical Center · R21 · FY2019 · AI
Narrow-Spectrum Drug Targets for Bacillus anthracis
$265,650Oklahoma State University Stillwater · R21 · FY2004 · AI
Training in Population Biology of Infectious Diseases
$265,620Leslie A. Real · Emory University · T32 · FY2009 · AI
Regulation by Botanicals of Pathogen-Specific Immune Defense
$265,563Eric G Pamer · Sloan-Kettering Inst Can Research · P50 · FY2009 · AT
The mycobiota, bone marrow transplantation, and clinical outcomes
$265,500Tobias M Hohl · Sloan-Kettering Inst Can Research · R21 · FY2021 · AI
Identification of novel anti-virulence compounds against Pathogenic Burkholderia
$265,500Matthew M Schaefers · Boston Children'S Hospital · R21 · FY2021 · AI
Subversion of Syndecan-1 Functions in Listeriosis
$265,500Pyong Woo Park · Boston Children'S Hospital · R21 · FY2021 · AI
Novel adjunctive therapy for drug resistant Gram-negative pathogens
$265,485Robert Ernest William Hancock · University Of British Columbia · R33 · FY2016 · AI